Annual Total Long Term Liabilities
$177.70 M
-$3.85 M-2.12%
31 December 2023
Summary:
IGM Biosciences annual total long term liabilities is currently $177.70 million, with the most recent change of -$3.85 million (-2.12%) on 31 December 2023. During the last 3 years, it has risen by +$168.12 million (+1755.45%). IGMS annual total long term liabilities is now -2.12% below its all-time high of $181.55 million, reached on 31 December 2022.IGMS Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$181.60 M
+$5.11 M+2.89%
30 September 2024
Summary:
IGM Biosciences quarterly total long term liabilities is currently $181.60 million, with the most recent change of +$5.11 million (+2.89%) on 30 September 2024. Over the past year, it has increased by +$4.07 million (+2.29%). IGMS quarterly long term liabilities is now at all-time high.IGMS Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IGMS Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.1% | +2.3% |
| 3 y3 years | +1755.5% | +593.1% |
| 5 y5 years | +191.7% | +1961.3% |
IGMS Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -2.1% | +1755.5% | at high | +613.9% |
| 5 y | 5 years | -2.1% | +1755.5% | at high | +1961.3% |
| alltime | all time | -2.1% | +1755.5% | at high | >+9999.0% |
IGM Biosciences Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $181.60 M(+2.9%) |
| June 2024 | - | $176.49 M(-0.3%) |
| Mar 2024 | - | $176.95 M(-0.4%) |
| Dec 2023 | $177.70 M(-2.1%) | $177.70 M(+0.1%) |
| Sept 2023 | - | $177.52 M(-0.1%) |
| June 2023 | - | $177.75 M(-1.1%) |
| Mar 2023 | - | $179.68 M(-1.0%) |
| Dec 2022 | $181.55 M(+613.7%) | $181.55 M(+7.9%) |
| Sept 2022 | - | $168.28 M(-1.6%) |
| June 2022 | - | $170.97 M(+561.3%) |
| Mar 2022 | - | $25.85 M(+1.6%) |
| Dec 2021 | $25.44 M | $25.44 M(-2.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $26.20 M(+186.5%) |
| June 2021 | - | $9.15 M(-9.0%) |
| Mar 2021 | - | $10.05 M(+4.9%) |
| Dec 2020 | $9.58 M(-21.8%) | $9.58 M(-6.6%) |
| Sept 2020 | - | $10.26 M(-6.2%) |
| June 2020 | - | $10.93 M(-5.7%) |
| Mar 2020 | - | $11.60 M(-5.3%) |
| Dec 2019 | $12.24 M(-79.9%) | $12.24 M(+39.0%) |
| Sept 2019 | - | $8.81 M(+4611.2%) |
| June 2019 | - | $187.00 K(-99.7%) |
| Dec 2018 | $60.92 M(+48.9%) | $60.92 M |
| Dec 2017 | $40.92 M | - |
FAQ
- What is IGM Biosciences annual total long term liabilities?
- What is the all time high annual total long term liabilities for IGM Biosciences?
- What is IGM Biosciences annual total long term liabilities year-on-year change?
- What is IGM Biosciences quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for IGM Biosciences?
- What is IGM Biosciences quarterly long term liabilities year-on-year change?
What is IGM Biosciences annual total long term liabilities?
The current annual total long term liabilities of IGMS is $177.70 M
What is the all time high annual total long term liabilities for IGM Biosciences?
IGM Biosciences all-time high annual total long term liabilities is $181.55 M
What is IGM Biosciences annual total long term liabilities year-on-year change?
Over the past year, IGMS annual total long term liabilities has changed by -$3.85 M (-2.12%)
What is IGM Biosciences quarterly total long term liabilities?
The current quarterly long term liabilities of IGMS is $181.60 M
What is the all time high quarterly long term liabilities for IGM Biosciences?
IGM Biosciences all-time high quarterly total long term liabilities is $181.60 M
What is IGM Biosciences quarterly long term liabilities year-on-year change?
Over the past year, IGMS quarterly total long term liabilities has changed by +$4.07 M (+2.29%)